loreev xr Drug Patent Profile
✉ Email this page to a colleague
When do Loreev Xr patents expire, and what generic alternatives are available?
Loreev Xr is a drug marketed by Almatica and is included in one NDA. There is one patent protecting this drug.
This drug has thirty-five patent family members in thirty countries.
The generic ingredient in LOREEV XR is lorazepam. There are eleven drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the lorazepam profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Loreev Xr
A generic version of loreev xr was approved as lorazepam by SANDOZ on April 21st, 1987.
Summary for loreev xr
International Patents: | 35 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 50 |
Patent Applications: | 4,397 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for loreev xr |
What excipients (inactive ingredients) are in loreev xr? | loreev xr excipients list |
DailyMed Link: | loreev xr at DailyMed |
![loreev xr drug patent expirations Drug patent expirations by year for loreev xr](/p/graph/s/t/loreev_xr-patent-expirations.png)
![Drug Prices for loreev xr](/p/graph/drug-price/loreev+xr.png)
Pharmacology for loreev xr
Drug Class | Benzodiazepine |
Anatomical Therapeutic Chemical (ATC) Classes for loreev xr
US Patents and Regulatory Information for loreev xr
loreev xr is protected by one US patents.
Patents protecting loreev xr
Sustained release formulations of lorazepam
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: ONCE DAILY TREATMENT OF ANXIETY DISORDER IN ADULTS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Almatica | LOREEV XR | lorazepam | CAPSULE, EXTENDED RELEASE;ORAL | 214826-001 | Aug 27, 2021 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Almatica | LOREEV XR | lorazepam | CAPSULE, EXTENDED RELEASE;ORAL | 214826-003 | Aug 27, 2021 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Almatica | LOREEV XR | lorazepam | CAPSULE, EXTENDED RELEASE;ORAL | 214826-004 | Feb 16, 2022 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Almatica | LOREEV XR | lorazepam | CAPSULE, EXTENDED RELEASE;ORAL | 214826-002 | Aug 27, 2021 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for loreev xr
See the table below for patents covering loreev xr around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 2897302 | FORMULATIONS A LIBERATION PROLONGEE DE LORAZEPAM (SUSTAINED RELEASE FORMULATIONS OF LORAZEPAM) | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2014110245 | ⤷ Sign Up | |
Russian Federation | 2015128915 | СОСТАВЫ ЛОРАЗЕПАМА С ЗАМЕДЛЕННЫМ ВЫСВОБОЖДЕНИЕМ | ⤷ Sign Up |
Israel | 239777 | תכשירים רוקחיים בעלי שחרור מושהה של לוראזפאם (Sustained release formulations of lorazepam) | ⤷ Sign Up |
Slovenia | 2943185 | ⤷ Sign Up | |
South Korea | 20150118119 | 로라제팜의 지속 방출성 제제 (SUSTAINED RELEASE FORMULATIONS OF LORAZEPAM) | ⤷ Sign Up |
Poland | 2943185 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |